Advances in large-scale genomic data production have led to a need for better methods to process, interpret, and organize this data. Starting with raw sequencing data, generating results requires many complex data processing steps, from quality control, alignment, and variant calling to genome wide association studies (GWAS) and characterization of expression quantitative trait loci (eQTL). In this dissertation, I present methods to address issues faced when working with large-scale genomic datasets. In Chapter 2, I present an analysis of 4,787 whole genomes sequenced for the study of age-related macular degeneration (AMD) as a follow-up fine-mapping study to previous work from the International AMD Genomics Consortium (IAMDGC). Through who...
The human body contains approximately 100 trillion cells, encompassing distinct cell types that serv...
Clinical genetic testing for rare monogenic diseases has the scope of identifying the disease-causin...
Alzheimer’s disease (AD) is a neurodegenerative disorder featuring progressive cognitive and functio...
Genome-wide association studies (GWAS), which examine common genetic variants in thousands of indivi...
In the past decade, advancement of genotyping technology, first microarray then “next-generation” se...
Searches for the elusive genetic mechanisms underlying complex diseases have long challenged human g...
Recent advances in genotyping and sequencing technologies have enabled genetic association studies t...
One aspect of the effort to disentangle the genetic component of complex traits is the mapping of g...
Structural variants (SVs), including copy number variants (CNVs), balanced rearrangements, and mobil...
Technological advances now allow investigators to use sequencing data to identify genetic risk varia...
Cancer is a heterogeneous group of diseases that currently takes over half a million lives per year ...
The DNA sequence analysis field has experienced a paradigm shift caused by the drastic reduction in ...
Genome-wide association (GWA) studies provide an extensive assessment of common genetic variants acr...
Genome-wide association studies (GWAS) have led to the identification of a plethora of risk-associat...
Mutation is the ultimate source of phenotypic variation. However, little is known about the effects ...
The human body contains approximately 100 trillion cells, encompassing distinct cell types that serv...
Clinical genetic testing for rare monogenic diseases has the scope of identifying the disease-causin...
Alzheimer’s disease (AD) is a neurodegenerative disorder featuring progressive cognitive and functio...
Genome-wide association studies (GWAS), which examine common genetic variants in thousands of indivi...
In the past decade, advancement of genotyping technology, first microarray then “next-generation” se...
Searches for the elusive genetic mechanisms underlying complex diseases have long challenged human g...
Recent advances in genotyping and sequencing technologies have enabled genetic association studies t...
One aspect of the effort to disentangle the genetic component of complex traits is the mapping of g...
Structural variants (SVs), including copy number variants (CNVs), balanced rearrangements, and mobil...
Technological advances now allow investigators to use sequencing data to identify genetic risk varia...
Cancer is a heterogeneous group of diseases that currently takes over half a million lives per year ...
The DNA sequence analysis field has experienced a paradigm shift caused by the drastic reduction in ...
Genome-wide association (GWA) studies provide an extensive assessment of common genetic variants acr...
Genome-wide association studies (GWAS) have led to the identification of a plethora of risk-associat...
Mutation is the ultimate source of phenotypic variation. However, little is known about the effects ...
The human body contains approximately 100 trillion cells, encompassing distinct cell types that serv...
Clinical genetic testing for rare monogenic diseases has the scope of identifying the disease-causin...
Alzheimer’s disease (AD) is a neurodegenerative disorder featuring progressive cognitive and functio...